JLM-BioCity Innovations

RenalSense Receives new Innovation Authority $828,000 R&D Grant

June 7, 2019

The Israeli Ministry of Economy and Industry and the Israel Innovation Authority have funded over NIS 25 million ($6.9 million) in grants to innovative medical technology

RenalSense Receives new Innovation Authority $828,000 R&D Grant

June 7, 2019

The Israeli Ministry of Economy and Industry and the Israel Innovation Authority have funded over NIS 25 million ($6.9 million) in grants to innovative medical technology

RenalSense Receives new Innovation Authority $828,000 R&D Grant

June 7, 2019

The Israeli Ministry of Economy and Industry and the Israel Innovation Authority have funded over NIS 25 million ($6.9 million) in grants to innovative medical technology

RespiDx’s spin-off, OmnySense, commercializes its comprehensive remote checkups Multimometer

June 7, 2019

RespiDx has created a new spin-off, OmnySense, to commercialize its Multimometer for comprehensive remote checkups. RespiDx has developed a technology platform for a comprehensive physiological check-up,

FameWave Acquisition Marks Kitov’s Transition Into Oncology

June 7, 2019

Kitov Pharma recently contracted an arrangement to acquire FameWave Ltd. for a share exchange transaction. FameWave shareholders will receive $10M worth of newly issued KTOV ADSs (U.S. Listing)

China’s Regulatory Authority [NMPA] Approves Oramed’s Oral Insulin Capsules IND Application

June 7, 2019

The Chinese partner of Oramed Pharmaceuticals Inc., Hefei Tianhui Incubator of Technologies Co., Ltd, has reached the significant regulatory milestone of approval of an investigational new drug application

Yarok Microbio combines Chemicals with AI to identify Dangerous Bacteria in Produce

May 14, 2019

Israeli startup Yarok Microbio says it has developed a way to identify life-threatening bacteria in as little as under an hour, before the food products they could

Insulin Replacement Company Betalin Therapeutics Raises $2.5m

April 28, 2019

Israeli diabetes treatment developer Betalin Therapeutics has raised $2.5 million from leading venture capital funds and private investors for its revolutionary treatment, which would replace insulin therapy.

Intec Pharma’s Pharmacokinetic Study of Accordion Pill™ Carbidopa/Levodopa 50/500 mg Dosed 3x Daily Report Positive Results

April 28, 2019

Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec”)presented the preliminary results from a pharmacokinetic (PK) study comparing the Company’s Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) 50/500mg dosed three times daily

To RSVP, contact Sara Gdanski, JLM-BioCity Corporate Relations Manager at 058-7922882

or email her at: sara.gdanski1 AT gmail.com

More JLM BioCity events coming soon…

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

- Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

The JLM Biocity networking events on Zoom keeps getting better. For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

- Ian Solomon CTO, OmnySense Ltd.

JLM-BioCity's events are well organized with a professional approach. You can feel a "homey" atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

- Dror Chevion CEO, Concenter BioPharma

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

- Immanuel Lerner CEO, Pepticom

Excellent event. Good speakers, interesting audience. Well done!

- Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

- Zeev Malyutin, Protein Department Head, Merck KGaA

Such an interesting lecture and great people attending!

- Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

Interesting - I could see it helping people network - a good thing!

- Jonathan Miller, Founder, President, and Designer, U-Step, Neurological Walking Aids

Great atmosphere, great people.

- Yael Ophir, Executive Director, HealthIL

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

Very informative and eye-opening event. Thank you for the great hospitality.

- Hemda Idel, founder, SLEEP ASAP

one of the best meetups organizations and a very important source of information and connections for startups.

Tal Or, Co-Founder, ATLASense Biomed Ltd.

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

Alexander Naslednikov, Founder and CEO, Med.me

<< Prev

Next >>

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.

RenalSense Receives new Innovation Authority $828,000 R&D Grant

RenalSense Receives new Innovation Authority $828,000 R&D Grant

RenalSense Receives new Innovation Authority $828,000 R&D Grant

RespiDx’s spin-off, OmnySense, commercializes its comprehensive remote checkups Multimometer

FameWave Acquisition Marks Kitov’s Transition Into Oncology

China’s Regulatory Authority [NMPA] Approves Oramed’s Oral Insulin Capsules IND Application

Yarok Microbio combines Chemicals with AI to identify Dangerous Bacteria in Produce

Insulin Replacement Company Betalin Therapeutics Raises $2.5m

Intec Pharma’s Pharmacokinetic Study of Accordion Pill™ Carbidopa/Levodopa 50/500 mg Dosed 3x Daily Report Positive Results

Strategic Partners

Platinum

Gold

Silver

Contact us at

Follow us

Copyright © 2020 JLM-BioCity | All rights reserved